Precision Cancer Tests market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Precision Cancer Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Precision Cancer Tests market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Imaging
In Vitro Diagnostic
Others
Segment by Application
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific